Products
2-(3-(TERT-BUTOXYCARBONYL)-3-AZASPIRO[5.5]UNDECAN-9-YL)ACETIC ACID
  • 2-(3-(TERT-BUTOXYCARBONYL)-3-AZASPIRO[5.5]UNDECAN-9-YL)ACETIC ACID2-(3-(TERT-BUTOXYCARBONYL)-3-AZASPIRO[5.5]UNDECAN-9-YL)ACETIC ACID

2-(3-(TERT-BUTOXYCARBONYL)-3-AZASPIRO[5.5]UNDECAN-9-YL)ACETIC ACID

Model: 952480-32-9
2-(3-(TERT-BUTOXYCARBONYL)-3-AZASPIRO[5.5]UNDECAN-9-YL)ACETIC ACID is a bifunctional spirocyclic building block in which a Boc-protected 3-azaspiro[5.5]undecane core is substituted at the 9-position with an acetic acid moiety. The spiro junction fuses a piperidine ring and a cyclohexane ring through a single quaternary carbon, enforcing a near-orthogonal orientation between the two rings. The tert-butoxycarbonyl group masks the secondary amine within the piperidine ring, while the pendant acetic acid extends outward from the cyclohexane ring, providing two chemically orthogonal reactive handles separated by a rigid, fully saturated framework. This structural arrangement establishes a well-defined distance and angle between the protected amine and the carboxylic acid, making the molecule a geometrically predictable scaffold for constructing more complex entities.

2-(3-(TERT-BUTOXYCARBONYL)-3-AZASPIRO[5.5]UNDECAN-9-YL)ACETIC ACID is a spirocyclic amino acid surrogate widely employed in medicinal chemistry as a conformationally constrained building block. The Boc-protected amine of 2-(3-(TERT-BUTOXYCARBONYL)-3-AZASPIRO[5.5]UNDECAN-9-YL)ACETIC ACID is stable under the basic and neutral conditions commonly used for carboxylic acid derivatization, enabling sequential functionalization: the acid can be coupled to amines or alcohols while the Boc group remains intact, after which acidic deprotection reveals the free amine for further elaboration. 2-(3-(TERT-BUTOXYCARBONYL)-3-AZASPIRO[5.5]UNDECAN-9-YL)ACETIC ACID has found application in the synthesis of spiro-containing peptidomimetics, where the rigid scaffold replaces flexible amino acid linkers and enforces a specific turn geometry. Because 2-(3-(TERT-BUTOXYCARBONYL)-3-AZASPIRO[5.5]UNDECAN-9-YL)ACETIC ACID is a fully synthetic, crystalline intermediate available in multi-gram quantities, it serves as a reliable stock reagent for hit-to-lead campaigns and library synthesis.


Product Parameters

Parameter

Specification

Product Name

2-(3-(TERT-BUTOXYCARBONYL)-3-AZASPIRO[5.5]UNDECAN-9-YL)ACETIC ACID

CAS Number

952480-32-9

Molecular Formula

C₁₇H₂₉NO₄

Molecular Weight

311.42 g/mol

Physical Form

Solid

Appearance

White to off-white powder or crystalline solid

Purity (HPLC)

Typically ≥95% or ≥98% depending on supplier grade

Storage Condition

2–8 °C, sealed, dry, protect from light


Product Advantages

1. Orthogonal protecting group strategy: The acid-labile Boc group on the piperidine nitrogen and the free carboxylic acid on the cyclohexane ring allow fully sequential chemical operations. The acid can be coupled under conditions that leave the Boc group unaffected, and subsequent treatment with TFA or HCl reveals the secondary amine for further derivatization, enabling efficient stepwise synthesis of complex spiro-containing structures.

2. Conformationally constrained scaffold: The spiro[5.5]undecane core eliminates rotational freedom between the two rings, enforcing a rigid spatial relationship between the protected amine and the carboxylic acid. This geometric predictability is valuable for designing peptidomimetics and receptor ligands where precise positioning of pharmacophoric elements is required.

3. Saturated, three-dimensional architecture: The all-carbon spiro framework, composed entirely of sp³-hybridized carbons, contributes to a high fraction of saturated carbons (Fsp³), a molecular property that has been correlated with improved clinical success rates and favorable physicochemical profiles.

4. Crystalline solid for ease of handling: The compound is a free-flowing powder or crystalline solid at ambient temperature, simplifying weighing, transfer, and storage in a laboratory setting.


Synthetic Route

The synthesis of spiro[5.5]undecane derivatives of this type is well-precedented in the patent and medicinal chemistry literature. A representative approach to constructing the 3-azaspiro[5.5]undecane core involves a double Michael addition or aldol condensation sequence starting from a 4-piperidone derivative and a suitably functionalized cyclohexanone or cyclohexenone building block, establishing the spiro junction. The acetic acid side chain can be introduced at the 9-position through Horner–Wadsworth–Emmons olefination followed by hydrogenation, or via other standard homologation methods. Boc protection of the piperidine nitrogen is typically achieved by treating the free amine with di-tert-butyl dicarbonate (Boc₂O) under basic conditions. Final hydrolysis of any ester intermediate yields the target carboxylic acid.


Storage Conditions

Store 2-(3-(TERT-BUTOXYCARBONYL)-3-AZASPIRO[5.5]UNDECAN-9-YL)ACETIC ACID in a tightly sealed container under an inert atmosphere (nitrogen or argon) at 2–8 °C. Protect from moisture, light, and excessive heat. Allow the container to equilibrate to ambient temperature before opening to avoid condensation. When stored as recommended, the compound is typically stable for a period of at least one to two years. Avoid exposure to strong acids (which may prematurely cleave the Boc group), strong oxidizing agents, and open flames.


Contact Us

Working on a project that demands a rigid, bifunctional spiro building block? Reach out to Cosperpharm today to request a sample, obtain a current Certificate of Analysis, or discuss your specific requirements for 2-(3-(TERT-BUTOXYCARBONYL)-3-AZASPIRO[5.5]UNDECAN-9-YL)ACETIC ACID. We are ready to support your discovery chemistry with reliable supply and responsive technical service.


Hot Tags: 2-(3-(TERT-BUTOXYCARBONYL)-3-AZASPIRO[5.5]UNDECAN-9-YL)ACETIC ACID, China, Manufacturer, Supplier, Factory
Send Inquiry
Contact Info
For inquiries about our products or pricelist, please leave your email to us and we will be in touch within 24 hours.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies.Privacy Policy
RejectAccept